Literature DB >> 7993980

Awakenings to the pathogenicity of urease and the requirement for continuous long term therapy.

H H LeVeen1, E G LeVeen, R F LeVeen.   

Abstract

Urease is an enzyme found in plants and bacteria, but not mammals. It catalyzes the conversion of urea to carbon dioxide and ammonia. Ammonia shortens the life span of cells; and higher concentrations cause tissue necrosis and cytolysis. Twenty percent of total body urea is converted to ammonia by bacterial urease in the colon. Small injections of urease immunize animals by producing antiurease, a gamma globulin, which inactivates urease. Immunization eliminates the colonic conversion of urea to ammonia. Injection of urease produces ammonia intoxication making immunization hazardous. Although previously impossible, a non enzymatic urease antigen was synthesized by covalently bonding jack bean urease with glutaraldehyde. This antigen stimulated the production of antiurease that inactivates native urease. Helicobacter pylori, a potent urease producer, has been implicated in peptic ulcer, gastritis and other inflammatory bowel lesions. The pathogenicity of H pylori is dependent on its urease production. Immunization to urease can render H pylori non pathogenic. Cirrhotics develop encephalopathy and hyperammonemia because their livers fail to convert all the ammonia in portal venous blood to urea and collaterals develop by passing the liver. Colonic ammonia increases the turnover rate of colonic mucosa. Ammonia absorbed into the portal venous system is transported to the liver where it is reconverted to urea. Absorbed ammonia adversely influences liver function. Infections with urease producing organisms destroy the renal parenchyma and produce struvite stones. Urease immunization aids colonic healing and prevents uremic colitis. Absorbed ammonia is a noxious influence on the liver. Animals immunized to urease regenerate the liver faster and are less susceptible to hepatotoxins. Immunization to urease ameliorates cirrhosis. Proteus and other urease producers become non toxic and do not damage the renal parenchyma. Urease is responsible for the pathogenicity of infections with urease producing organisms. Immunization to urease renders urease producing organisms non pathogenic.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7993980     DOI: 10.1016/0753-3322(94)90104-x

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

Authors:  I A Scotiniotis; M R Lucey; D C Metz
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

2.  Current concepts in the pathophysiology and management of hepatic encephalopathy.

Authors:  R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

3.  Helicobacter pylori, ammonia and the brain.

Authors:  S D Taylor-Robinson; N Jackson; C Buckley
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

4.  Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women.

Authors:  Shunji Fujimori; Teruyuki Kishida; Tsuyoshi Kobayashi; Yoshihisa Sekita; Tsuguhiko Seo; Kazuhiro Nagata; Atsushi Tatsuguchi; Katya Gudis; Kimiyoshi Yokoi; Noritake Tanaka; Kiyohiko Yamashita; Takashi Tajiri; Yoshiharu Ohaki; Choitsu Sakamoto
Journal:  J Gastroenterol       Date:  2005-09       Impact factor: 7.527

5.  Elevated risk of recurrent colorectal neoplasia with Helicobacter pylori-associated chronic atrophic gastritis: A follow-up study of patients with endoscopically resected colorectal neoplasia.

Authors:  Izumi Inoue; Jun Kato; Noriko Yoshimura; Yoshimasa Maeda; Kosaku Moribata; Naoki Shingaki; Hisanobu Deguchi; Shotaro Enomoto; Takao Maekita; Kazuki Ueda; Mikitaka Iguchi; Hideyuki Tamai; Mitsuhiro Fujishiro; Nobutake Yamamichi; Tatsuya Takeshita; Masao Ichinose
Journal:  Mol Clin Oncol       Date:  2012-09-11

6.  Association of Helicobacter pylori with elevated blood ammonia levels in cirrhotic patients: a meta-analysis.

Authors:  Hai-Xing Jiang; Shan-Yu Qin; Zhi-gang Min; Ming-Zhi Xie; Tao Lin; Bang-Li Hu; Xiao-Yun Guo
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

Review 7.  Canine gastritis.

Authors:  Craig Webb; David C Twedt
Journal:  Vet Clin North Am Small Anim Pract       Date:  2003-09       Impact factor: 2.093

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.